TheStreet Lowers Viewray (VRAY) to D

TheStreet cut shares of Viewray (NASDAQ:VRAY) from a c- rating to a d rating in a research note published on Friday, TheStreetRatingsTable reports.

A number of other research firms have also commented on VRAY. B. Riley reaffirmed a buy rating and issued a $12.00 price objective (down from $13.75) on shares of Viewray in a research note on Monday, March 11th. ValuEngine raised Viewray from a hold rating to a buy rating in a research note on Tuesday, February 19th. BidaskClub lowered Viewray from a buy rating to a hold rating in a research note on Saturday, March 16th. Zacks Investment Research lowered Viewray from a strong-buy rating to a hold rating in a research note on Wednesday, March 20th. Finally, Guggenheim assumed coverage on Viewray in a research note on Tuesday, January 15th. They issued a buy rating and a $13.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of $12.63.

Viewray stock opened at $8.17 on Friday. The company has a current ratio of 5.15, a quick ratio of 4.24 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $771.74 million, a P/E ratio of -8.34 and a beta of 1.20. Viewray has a one year low of $4.86 and a one year high of $13.21.

Viewray (NASDAQ:VRAY) last posted its quarterly earnings data on Thursday, May 2nd. The company reported ($0.34) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.22) by ($0.12). The company had revenue of $20.30 million during the quarter, compared to analyst estimates of $20.40 million. Viewray had a negative return on equity of 73.11% and a negative net margin of 139.82%. Viewray’s revenue was down 22.5% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.11) earnings per share. Equities analysts predict that Viewray will post -0.89 earnings per share for the current fiscal year.

Large investors have recently modified their holdings of the company. Northern Trust Corp raised its position in shares of Viewray by 2.7% during the fourth quarter. Northern Trust Corp now owns 836,280 shares of the company’s stock worth $5,077,000 after purchasing an additional 22,187 shares during the period. BlackRock Inc. grew its holdings in Viewray by 51.9% during the third quarter. BlackRock Inc. now owns 4,501,045 shares of the company’s stock worth $42,130,000 after buying an additional 1,538,108 shares in the last quarter. Essex Investment Management Co. LLC grew its holdings in Viewray by 2.9% during the fourth quarter. Essex Investment Management Co. LLC now owns 245,232 shares of the company’s stock worth $1,489,000 after buying an additional 6,897 shares in the last quarter. Pennsylvania Trust Co grew its holdings in Viewray by 31.7% during the fourth quarter. Pennsylvania Trust Co now owns 126,341 shares of the company’s stock worth $767,000 after buying an additional 30,396 shares in the last quarter. Finally, Prescott Group Capital Management L.L.C. grew its holdings in Viewray by 1,141.9% during the fourth quarter. Prescott Group Capital Management L.L.C. now owns 200,476 shares of the company’s stock worth $1,217,000 after buying an additional 184,333 shares in the last quarter.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Read More: Outstanding Shares, Buying and Selling Stocks

Analyst Recommendations for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.